openPR Logo
Press release

Asia-Pacific Metered Dose Inhaler Market Size, Share |Industry Growth and Forecast 2019-2025

Asia-Pacific Metered Dose Inhaler Market Size, Share |Industry

Asia-Pacific metered dose inhaler market is anticipated to grow at a substantial rate of around 4.5% during the forecast period. Major factors that augment the growth of the market include a large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and the significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by big pharmaceutical companies in life science research coupled with harnessing innovation. The metered dose inhaler market in the Asia-Pacific region promises future opportunities for growth as the prevalence of respiratory diseases such as asthma, COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growth of the market.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/asia-pacific-metered-dose-inhaler-market

The Asia-Pacific metered dose inhaler market is segmented on the basis of device type, application, and end-user. On the basis of device type, the market is sub-segmented into the metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have the largest market share in the Asia-Pacific metered dose inhaler market due to providing an easy inhalation solution. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

A full report of Asia-Pacific metered dose inhaler market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-metered-dose-inhaler-market

Asia-Pacific metered dose inhaler market - Segmentation

By Type

• Preventive Inhaler
• Reliever Inhaler
• Long Acting Bronchodilators Inhaler

By Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By End-User

• Homecare
• Hospitals and Clinics

Company Profiles

• 3M Co.
• Acorda Therapeutics, Inc.
• Adamis Pharmaceuticals Corp.
• Adherium Ltd.
• Aradigm Corp.
• AstraZeneca PLC
• Beximo Pharmaceuticals Ltd.
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• GlaxoSmithKline PLC
• Koninklijke Philips N.V.
• MidasCare Pharmaceutical Pvt. Ltd.
• Novartis AG
• Omron Healthcare Inc.
• ResMed Corp.
• Sunovion Pharmaceuticals
• Teijin Pharma Ltd.
• Teva Pharmaceuticals Industries Ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-metered-dose-inhaler-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Metered Dose Inhaler Market Size, Share |Industry Growth and Forecast 2019-2025 here

News-ID: 1900518 • Views:

More Releases from Orion Market Research Pvt. Ltd.

Insurance CRM Software Market Trends, Business Overview, Industry Growth and Forecast to 2031
Insurance CRM Software Market Trends, Business Overview, Industry Growth and For …
The global insurance CRM software market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the global insurance CRM software market during the forecast period is demand for the smart and automated technologies by the insurance companies. Get Free Sample link @ https://www.omrglobal.com/request-sample/insurance-crm-software-market-share The insurance CRM software will help the insurance companies with policy tracking, agent management, activity tracking, and many
Smart Meters Market 2022 Driving Factors Forecast Research 2028
Smart Meters Market 2022 Driving Factors Forecast Research 2028
The global market for smart meters is projected to have considerable CAGR of around 7.5% during the forecast period. The market growth mainly backed by the increasing inclination towards smart meters in place of conventional meters due to various advantages, such as theft detection and leakage management further raises the demand for smart meters across the globe. The smart meters provides theft and accurate billing and enhanced customer services by
Prostate Stents Market Current Status, In-depth Analysis and Forecast Outlook 20 …
A prostate stent is a medical device used to open the space surrounding the prostate urethra and bladder neck for smooth urine flow during urinary incontinence. These stents are effective in relieving bladder outlet obstruction caused by benign prostatic hyperplasia (common in men over 70). (Get 15% Discount on Buying this Report) Get Sample at: https://www.orionmarketreports.com/request-sample/?id=50469 Market Segments The global prostate stents market can be bifurcated into permanent and temporary. Several studies have
Rapid Pregnancy Tests Market Current Status, In-depth Analysis and Forecast Outl …
The pregnancy test kit confirms pregnancy by detecting the level of human chorionic gonadotropin (HCG) in the urine. The growing demand for an easy and convenient way to get faster results, and the easy availability of pregnancy kits through various distribution channels, including pharmacies/pharmacies, online stores, etc., is increasing the demand for pregnancy test kits. (Get 15% Discount on Buying this Report) Get Sample at: https://www.orionmarketreports.com/request-sample/?id=50471 Market Segments Based on product type The global

All 5 Releases


More Releases for Inhaler

12-09-2024 | Health & Medicine
Getnews
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and